Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Immunology and Allergy Clinics of North America
|
April 26, 2025
The Current and Future of Biomarkers of Immune Related Adverse Events
William Bracamonte-Baran, Sang T Kim
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 9, 2026
Immune checkpoint inhibitor-associated inflammatory arthritis
Sang T Kim, Anne R Bass
Rheumatic Diseases Clinics of North America
|
April 26, 2024
The Current and Future of Biomarkers of Immune Related Adverse Events
William Bracamonte-Baran, Sang T Kim
Expert Review of Clinical Immunology
|
December 28, 2018
Managing immune dysregulation resulting from immune checkpoint inhibitors: impact of the ASCO guidelines and key take-homes for immunologists
Sang T Kim, Maria E Suarez-Almazor
Cancers
|
August 7, 2021
Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis
Emma Rodriguez, Guangsheng Pei, Sang T Kim, et al.
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
RS3PE Following Treatment With Combination of Hormonal Therapies Plus Ipilimumab in a Patient With Metastatic Prostate Cancer
Sang T Kim, William A Murphy, Ana Aparicio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 14, 2017
Review: Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer
Maria E Suarez-Almazor, Sang T Kim, Noha Abdel-Wahab, et al.
Cancers
|
October 23, 2021
Erratum: Rodriguez et al. Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. <i>Cancers</i> 2021, <i>13</i>, 3871
Emma Rodriguez, Guangsheng Pei, Zhongming Zhao, et al.
Current Alzheimer Research
|
September 13, 2018
Mapping Exchangeable Protons to Monitor Protein Alterations in the Brain of an Alzheimer's Disease Mouse Model by Using MRI
Geon-Ho Jahng, Wonmin Choi, Julius J Chung, et al.
AACE Clinical Case Reports
|
June 12, 2020
A CASE OF ACQUIRED GENERALIZED LIPODYSTROPHY ASSOCIATED WITH PEMBROLIZUMAB IN A PATIENT WITH METASTATIC MALIGNANT MELANOMA
Sara Bedrose, Christie G Turin, Victor R Lavis, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Immunology and Allergy Clinics of North America
|
April 26, 2025
The Current and Future of Biomarkers of Immune Related Adverse Events
William Bracamonte-Baran, Sang T Kim
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 9, 2026
Immune checkpoint inhibitor-associated inflammatory arthritis
Sang T Kim, Anne R Bass
Rheumatic Diseases Clinics of North America
|
April 26, 2024
The Current and Future of Biomarkers of Immune Related Adverse Events
William Bracamonte-Baran, Sang T Kim
Expert Review of Clinical Immunology
|
December 28, 2018
Managing immune dysregulation resulting from immune checkpoint inhibitors: impact of the ASCO guidelines and key take-homes for immunologists
Sang T Kim, Maria E Suarez-Almazor
Cancers
|
August 7, 2021
Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis
Emma Rodriguez, Guangsheng Pei, Sang T Kim, et al.
Journal of Immunotherapy and Precision Oncology
|
June 6, 2022
RS3PE Following Treatment With Combination of Hormonal Therapies Plus Ipilimumab in a Patient With Metastatic Prostate Cancer
Sang T Kim, William A Murphy, Ana Aparicio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
January 14, 2017
Review: Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer
Maria E Suarez-Almazor, Sang T Kim, Noha Abdel-Wahab, et al.
Cancers
|
October 23, 2021
Erratum: Rodriguez et al. Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. <i>Cancers</i> 2021, <i>13</i>, 3871
Emma Rodriguez, Guangsheng Pei, Zhongming Zhao, et al.
Current Alzheimer Research
|
September 13, 2018
Mapping Exchangeable Protons to Monitor Protein Alterations in the Brain of an Alzheimer's Disease Mouse Model by Using MRI
Geon-Ho Jahng, Wonmin Choi, Julius J Chung, et al.
AACE Clinical Case Reports
|
June 12, 2020
A CASE OF ACQUIRED GENERALIZED LIPODYSTROPHY ASSOCIATED WITH PEMBROLIZUMAB IN A PATIENT WITH METASTATIC MALIGNANT MELANOMA
Sara Bedrose, Christie G Turin, Victor R Lavis, et al.
Page
of 3